The combined observations from these two datasets (GSE161731 and GSE157103) showed the stepwise increase of S100A12 activation in COVID-19 patients from non-hospitalized patients to hospitalized patients, and from hospitalized non-ICU patients to ICU patients. This evidence concerns the gene S100A12 and COVID-19.